Cite
HARVARD Citation
Xie, J. et al. (2019). Ixazomib – the first oral proteasome inhibitor. Leukemia & lymphoma. 60 (3), pp. 610-618. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, J. et al. (2019). Ixazomib – the first oral proteasome inhibitor. Leukemia & lymphoma. 60 (3), pp. 610-618. [Online].